908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp Acquires 10,000 Shares of Stock

908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp purchased 10,000 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were acquired at an average price of $5.60 per share, for a total transaction of $56,000.00. Following the purchase, the chief executive officer now directly owns 468,981 shares in the company, valued at $2,626,293.60. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

908 Devices Stock Performance

Shares of 908 Devices stock opened at $5.70 on Wednesday. The stock has a market cap of $187.99 million, a P/E ratio of -5.33 and a beta of 1.02. The stock’s fifty day moving average is $6.48 and its 200 day moving average is $7.08. 908 Devices Inc. has a one year low of $4.85 and a one year high of $12.51.

908 Devices (NASDAQ:MASS) last posted its quarterly earnings data on Tuesday, April 30th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.03. The firm had revenue of $9.99 million for the quarter, compared to the consensus estimate of $9.29 million. 908 Devices had a negative return on equity of 20.47% and a negative net margin of 68.57%. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the company earned ($0.39) earnings per share. Analysts predict that 908 Devices Inc. will post -1.11 EPS for the current year.

Hedge Funds Weigh In On 908 Devices

Hedge funds have recently modified their holdings of the company. Granahan Investment Management LLC raised its position in shares of 908 Devices by 10.6% during the 4th quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock valued at $22,874,000 after purchasing an additional 195,368 shares during the period. Iron Triangle Partners LP raised its holdings in 908 Devices by 31.1% during the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock valued at $14,417,000 after acquiring an additional 304,484 shares during the period. New York State Common Retirement Fund lifted its position in shares of 908 Devices by 5.0% in the fourth quarter. New York State Common Retirement Fund now owns 74,033 shares of the company’s stock valued at $831,000 after acquiring an additional 3,508 shares in the last quarter. ARK Investment Management LLC boosted its stake in shares of 908 Devices by 8.3% in the fourth quarter. ARK Investment Management LLC now owns 4,346,579 shares of the company’s stock worth $48,769,000 after acquiring an additional 333,119 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of 908 Devices during the fourth quarter worth about $133,000. 88.06% of the stock is currently owned by institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.